Batavia Biosciences is a CDMO founded in 2010 and based in the Netherlands. The company's services include viral vectors, viral vaccines, and proteins and antibodies. Batavia currently employs over 100 industry experts, and over the past 13 years has completed over 500 projects, with 97% of their successful runs being under GMP. They also have a number of novel technologies to combat issues and reduce costs associated with viral vector production.